Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-09 · accession 0001209191-22-045230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-10 | 2022-08-09 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $2.43 | +78.1K | 262.5K | +42% | +$189.7K |
| DM | 2022-08-10 | 2022-08-09 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $0.00 | -78.1K | 140.3K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-09 | M | A | 70,177 | $1.53 | 254,584 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-09 | M | A | 7,916 | $10.40 | 262,500 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-08-09 | M | D | 7,916 | $0.00 | 125,416 | D | $10.40 · — to 2029-07-12 | 7,916 Common Stock | (F2) 1/4 of the shares subject to the stock option vested and become exercisable on July 12, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-08-09 | M | D | 70,177 | $0.00 | 140,328 | D | $1.53 · — to 2028-01-26 | 70,177 Common Stock | (F1) The option is fully vested and exercisable. |